Loading…
Bausch + Lomb Corporation is projected to rise to $19.17 by 2027, a +22% move from its current price of $15.72. BLCO is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $15.54 | $15.73 | $15.92 | +0.04% |
| May 30 | $15.46 | $15.73 | $16.01 | +0.08% |
| May 31 | $15.41 | $15.74 | $16.08 | +0.12% |
| Jun 1 | $15.37 | $15.75 | $16.13 | +0.17% |
| Jun 2 | $15.33 | $15.75 | $16.19 | +0.21% |
| Jun 3 | $15.30 | $15.76 | $16.24 | +0.25% |
| Jun 4 | $15.27 | $15.77 | $16.28 | +0.29% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $15.27 | $15.77 | $16.28 | +0.29% |
| Week 2 | $15.11 | $15.81 | $16.55 | +0.58% |
| Week 3 | $15.00 | $15.86 | $16.77 | +0.88% |
| Week 4 | $14.91 | $15.90 | $16.96 | +1.17% |
| Week 5 | $14.84 | $15.95 | $17.14 | +1.47% |
| Week 6 | $14.78 | $16.00 | $17.31 | +1.76% |
| Week 7 | $14.73 | $16.04 | $17.47 | +2.06% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lenses that cover the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provide optical correction during healing.
It also offers contact lens care products, eye vitamins, mineral supplements, and over-the-counter eye drops that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. The Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery.
The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc.
BLCO is a healthcare stock focused on eye health, categorized under Healthcare. It trades with a current price of $15.92 and a market cap of $5.68B, and it holds a position at rank 1255. The stock is shown with a neutral near-term technical stance, with key support and resistance levels identified around its recent price action.
A major floor 8.1% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.4% away) — a key level to hold.
The nearest ceiling, 7.4% above — a clean break opens room to run.
A major ceiling 18.3% above — clearing it would confirm fresh momentum.
Key BLCO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BLCO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $15.95 | Sell | $15.89 | Sell |
| MA 10 | $16.07 | Sell | $15.98 | Sell |
| MA 20 | $16.03 | Sell | $16.05 | Sell |
| MA 50 | $16.12 | Sell | $16.24 | Sell |
| MA 100 | $16.69 | Sell | $16.32 | Sell |
| MA 200 | $16.07 | Sell | $16.08 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 40.64 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -122.25 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | -2.84 | Sell |
| Bollinger %B (20,2) | 0.16 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.05 | Sell |
| Awesome (5,34) | -0.20 | Sell |
| Ultimate (7,14,28) | 28.14 | Buy |
| Momentum (10) | -0.31 | Sell |
| Aroon Osc (25) | 8.00 | Buy |
| Hull MA (9) | 15.78 | Sell |
| ADX (14) | 8.42 | Neutral |
| ATR (14) | 0.15 | Info |
Near-term momentum is neutral, with RSI(14) at 40. The stock trades around the 50-day and 200-day simple moving averages, which are $16.14 and $16.05 respectively. Support is at $15.34 and resistance at $16.88. Over the last 30 days, the price range has been $14.63 to $17.32, indicating a modest, sideways drift in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $15.26 | $15.72 | $22.13 | 0% | Neutral | |
| $15.66 | $19.17 | $24.56 | +22% | Bullish | |
| $17.63 | $21.98 | $28.90 | +40% | Bullish | |
| $18.02 | $22.81 | $30.61 | +45% | Bullish | |
| $18.47 | $23.68 | $32.34 | +51% | Bullish | |
| $21.09 | $27.37 | $37.97 | +74% | Bullish | |
| $24.33 | $31.93 | $44.91 | +103% | Bullish | |
| $27.17 | $36.02 | $51.32 | +129% | Bullish | |
| $28.16 | $37.71 | $54.37 | +140% | Bullish | |
| $28.24 | $38.16 | $55.62 | +143% | Bullish | |
| $42.06 | $59.29 | $90.53 | +277% | Bullish | |
| $71.76 | $108.46 | $177.47 | +590% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $15.26 | $15.72 | $18.37 | +0.00% |
| June 2026 | $13.47 | $15.72 | $18.69 | -0.01% |
| July 2026 | $13.92 | $16.33 | $19.60 | +3.87% |
| August 2026 | $14.37 | $16.93 | $20.47 | +3.70% |
| September 2026 | $14.35 | $16.98 | $20.65 | +0.28% |
| October 2026 | $14.48 | $17.19 | $21.02 | +1.23% |
| November 2026 | $14.92 | $17.77 | $21.83 | +3.36% |
| December 2026 | $15.02 | $17.93 | $22.13 | +0.94% |
Click any year to see its month-by-month BLCO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The BLCO price prediction for 2026 points to an average of $15.72 (low $15.26, high $22.13) — a potential gain of 0% on today's $15.72. A consolidation phase looks the most probable path here.
In 2027, BLCO is projected to trade between $15.66 and $24.56, averaging $19.17 — a potential gain of +22% from today's $15.72. That is up +22% on the projected 2026 average. Momentum favours further upside here.
Bausch + Lomb Corporation's 2028 outlook centres on $21.98, within a $17.63 to $28.90 range. That is up +15% on the projected 2027 average. That marks a +40% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, BLCO could reach as high as $30.61, with a base case around $22.81 and support toward $18.02 — roughly +45% from $15.72. Momentum favours further upside here.
Expect BLCO to range from $18.47 to $32.34 through 2030. The $23.68 average target implies a +51% move from current prices. That is up +4% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The BLCO price prediction for 2031 points to an average of $27.37 (low $21.09, high $37.97) — a potential gain of +74% on today's $15.72. Momentum favours further upside here.
In 2032, BLCO is projected to trade between $24.33 and $44.91, averaging $31.93 — a potential gain of +103% from today's $15.72. That is up +17% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Bausch + Lomb Corporation's 2033 outlook centres on $36.02, within a $27.17 to $51.32 range. That is up +13% on the projected 2032 average. That marks a +129% change versus current levels. Momentum favours further upside here.
By 2034, BLCO could reach as high as $54.37, with a base case around $37.71 and support toward $28.16 — roughly +140% from $15.72. Buyers look set to stay in control over this stretch.
Expect BLCO to range from $28.24 to $55.62 through 2035. The $38.16 average target implies a +143% move from current prices. That is up +1% on the projected 2034 average. Momentum favours further upside here.
The BLCO price prediction for 2040 points to an average of $59.29 (low $42.06, high $90.53) — a potential gain of +277% on today's $15.72. Buyers look set to stay in control over this stretch.
In 2050, BLCO is projected to trade between $71.76 and $177.47, averaging $108.46 — a potential gain of +590% from today's $15.72. That is up +83% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in BLCO today (≈ 63.613232 BLCO) could be worth
$6,899.61
+$5,899.61 (+590%) by 2050 · US Dollar
Based on the average projected BLCO price of $108.46 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BLCOwould be worth at today's price.
$1,000 invested in BLCO on May 27, 2025 (≈ 84.745761 BLCO) would be worth
$1,332.2
+$332.2 (+33.2%) today · 1.33× · US Dollar
Based on a BLCO entry price of $11.8 vs. today's $15.72.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $16.2 | $970.37 | -3.0% |
| 1 month ago | $15.88 | $989.92 | -1.0% |
| 3 months ago | $18.49 | $850.19 | -15.0% |
| 6 months ago | $16.19 | $970.97 | -2.9% |
| 1 year ago | $11.8 | $1,332.2 | +33.2% |
| All time (4.1y) ago | $20 | $786 | -21.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BLCO forecast.
Our base-case forecast reaches $31.00 around 2032.
Implied market cap at $31.00: $11.05B
The multi-year forecast shows a path of rising prices with bullish sentiment from 2027 onward. By 2030, the average price is forecast at $24.19, with a min of $18.86 and a max of $33.04, corresponding to an ROI of 51.9%. By 2040, the average reaches $61.55 with a max of $93.99 and a min of $43.66, delivering an ROI of 286.6%.
By 2050, the average is $112.43 with a max of $183.98 and a min of $74.38, delivering an ROI of 606.2%. The forecast from 2027 onward is labeled BULLISH, reflecting substantial upside potential as the stock price rises well above current levels. The forecast also shows volatility, with an annualized volatility of 20%.
While these figures illustrate meaningful upside, they are estimates and not guarantees, and actual results may vary.
Tap a question to reveal the answer.
In 2030 the forecasted average price is $24.19, with a minimum of $18.86 and a maximum of $33.04, and an ROI of 51.9%. The sentiment is BULLISH.
The forecast from 2027 onward is BULLISH, with the 2027 average price forecast at $19.49 and an eventual 2030 average of $24.19 (ROI 51.9%). Higher-year forecasts continue to rise, reaching $61.55 by 2040 and $112.43 by 2050 (ROIs of 286.6% and 606.2%, respectively). The outlook carries uncertainty and reflects volatility, with an annualized volatility of 20%.
Yes. The forecast indicates a path that reaches an average of $112.43 by 2050, with a max of $183.98 and a min of $74.38, corresponding to a 606.2% ROI. Earlier years also show rising averages, culminating in bullish long-term upside.
Current price is $15.92 and the market cap is $5.68B. BLCO is ranked 1255.
RSI(14) is 40, indicating neutral momentum. The 50-day SMA is $16.14 and the 200-day SMA is $16.05. Near-term support is $15.34 and resistance is $16.88, with the 30-day price range between $14.63 and $17.32.
Bausch + Lomb Corporation Community Discussion
0Share your Bausch + Lomb Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.